Mitomycin C 2 mg Injection 2 ml belongs to a group of medicines known as 'anti-cancer' used in cancer therapy. It is most effective in the treatment of advanced metastatic stomach cancer (stomach carcinoma), advanced and/or metastatic breast cancer (breast carcinoma), cancer of the respiratory tract (non-small cell bronchial carcinoma), and advanced cancer of the pancreas (pancreatic carcinoma). Cancer is a condition where cells in a specific body part grow and reproduce uncontrollably. The cancerous cells can attack and destroy surrounding healthy tissue, including organs. Cancer sometimes begins in one body part before spreading to other areas. This process is known as metastasis.

Mitomycin C 2 mg Injection 2 ml contains Mitomycin, an anti-cancer medication that is cytotoxic (causes cell death). It works by inhibiting the genetic material's development (DNA) in a cell (cancer cell), thereby stopping cancer cells from dividing. As a result, cancer cell growth and spread stopped or slowed.

Healthcare professionals administer Mitomycin C 2 mg Injection 2 ml. It is intended to be used as an injection or infusion into a blood vessel. Depending upon your medical condition, you are advised to take Mitomycin C 2 mg Injection 2 ml for as long as your doctor has prescribed it for you. In some cases, you may experience certain common side effects such as nausea, vomiting, hair loss, kidney disorders, fever, and lung disorders. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.

Before taking Mitomycin C 2 mg Injection 2 ml, inform your doctor if you have any infection because Mitomycin C 2 mg Injection 2 ml may worsen the infection. Some patients may experience increased sensitivity to light while taking Mitomycin C 2 mg Injection 2 ml, and avoiding prolonged exposure to sunlight is recommended. Inform your doctor if you are pregnant as Mitomycin C 2 mg Injection 2 ml can cause harmful effects on the unborn baby. Both women and men using this Mitomycin C 2 mg Injection 2 ml should use birth control to avoid pregnancy. You should not take this Mitomycin C 2 mg Injection 2 ml during breastfeeding. Inform your doctor if you take Mitomycin C 2 mg Injection 2 ml. Use the Mitomycin C 2 mg Injection 2 ml with caution in elderly patients. Do not take live vaccines three months after your last chemotherapy. Before starting therapy, your doctor may recommend you undergo tests for lung, kidney, and liver function to exclude any diseases.

Mitomycin C 2 mg Injection 2 ml belongs to the group of anti-cancer medicines containing Mitomycin. It works by inhibiting the genetic material's development (DNA) in a cell (cancer cell), thereby destroying quickly dividing cells. As a result, the growth and spread of cancer cells in stopped or slowed down.

Before taking the Mitomycin C 2 mg Injection 2 ml, inform your doctor if you have any active infection. Some patients may experience increased sensitivity to light while taking Mitomycin C 2 mg Injection 2 ml and avoiding prolonged exposure to sunlight is recommended. Consult your doctor if you are pregnant as Mitomycin C 2 mg Injection 2 ml can cause harmful effects on the unborn baby. Both women and men using this Mitomycin C 2 mg Injection 2 ml should use birth control to avoid pregnancy. You should not take Mitomycin C 2 mg Injection 2 ml during breastfeeding. Use the Mitomycin C 2 mg Injection 2 ml with caution in elderly patients. Inform your doctor if you have impaired lung, kidney, or liver function, urinary bladder inflammation, or are undergoing radiation therapy. Mitomycin C 2 mg Injection 2 ml is not recommended for use in children and adolescents.